Multiple sclerosis progression: time for a new mechanism-driven framework

T Kuhlmann, M Moccia, T Coetzee, JA Cohen… - The Lancet …, 2023 - thelancet.com
Traditionally, multiple sclerosis has been categorised by distinct clinical descriptors—
relapsing-remitting, secondary progressive, and primary progressive—for patient care …

PET imaging of neuroinflammation in neurological disorders

WC Kreisl, MJ Kim, JM Coughlin, ID Henter… - The Lancet …, 2020 - thelancet.com
A growing need exists for reliable in-vivo measurement of neuroinflammation to better
characterise the inflammatory processes underlying various diseases and to inform the …

Microglia in multiple sclerosis: friend or foe?

BL Guerrero, NL Sicotte - Frontiers in immunology, 2020 - frontiersin.org
Microglia originate from myeloid progenitors in the embryonic yolk sac and play an integral
role in central nervous system (CNS) development, immune surveillance and repair. The …

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions

C Elliott, JS Wolinsky, SL Hauser… - Multiple Sclerosis …, 2019 - journals.sagepub.com
Background: Chronic lesion activity driven by smoldering inflammation is a pathological
hallmark of progressive forms of multiple sclerosis (MS). Objective: To develop a method for …

Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions

UW Kaunzner, Y Kang, S Zhang, E Morris, Y Yao… - Brain, 2019 - academic.oup.com
Chronic active multiple sclerosis lesions, characterized by a hyperintense rim of iron-
enriched, activated microglia and macrophages, have been linked to greater tissue damage …

Imaging chronic active lesions in multiple sclerosis: a consensus statement

F Bagnato, P Sati, CC Hemond, C Elliott, SA Gauthier… - Brain, 2024 - academic.oup.com
Chronic active lesions (CAL) are an important manifestation of chronic inflammation in
multiple sclerosis (MS) and have implications for non-relapsing biological progression. In …

Microglia in multiple sclerosis–pathogenesis and imaging

L Airas, VW Yong - Current Opinion in Neurology, 2022 - journals.lww.com
Microglia in multiple sclerosis – pathogenesis and imaging : Current Opinion in Neurology
Microglia in multiple sclerosis – pathogenesis and imaging : Current Opinion in Neurology Log …

[HTML][HTML] Chronic lesion activity and disability progression in secondary progressive multiple sclerosis

V Beynon, IC George, C Elliott, DL Arnold, J Ke… - BMJ neurology …, 2022 - ncbi.nlm.nih.gov
Objective Slowly expanding lesions (SELs), a subgroup of chronic white matter lesions that
gradually expand over time, have been shown to predict disability accumulation in primary …

Evaluation of microglial activation in multiple sclerosis patients using positron emission tomography

L Airas, M Nylund, E Rissanen - Frontiers in Neurology, 2018 - frontiersin.org
Understanding the mechanisms underlying progression in multiple sclerosis (MS) is one of
the key elements contributing to the identification of appropriate therapeutic targets for this …

Innate immune cell–related pathology in the thalamus signals a risk for disability progression in multiple sclerosis

O Misin, M Matilainen, M Nylund… - Neurology …, 2022 - AAN Enterprises
Background and Objectives Our aim was to investigate whether 18-kDa translocator protein
(TSPO) radioligand binding in gray matter (GM) predicts later disability progression in …